![Anne Chun Longo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anne Chun Longo
Algemeen Directeur bij PharmatrophiX, Inc.
Profiel
Anne Chun Longo is currently the Chief Executive Officer at PharmatrophiX, Inc. She started this position in 2006.
She completed her undergraduate degree at Stanford University.
Actieve functies van Anne Chun Longo
Bedrijven | Functie | Begin |
---|---|---|
PharmatrophiX, Inc.
![]() PharmatrophiX, Inc. BiotechnologyHealth Technology PharmatrophiX, Inc. develops a drug technology targeting neurodegenerative disorders. The firm is currently focusing on Alzheimer''s disease treatment. It has two development programs, p75 receptor program and Trk ligand program which targets a spectrum of neurological and non-neurological disorders. The company was founded by Frank M. Longo in 2005 and is headquartered in Raleigh, NC. | Algemeen Directeur | 01-01-2006 |
Opleiding van Anne Chun Longo
Stanford University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
PharmatrophiX, Inc.
![]() PharmatrophiX, Inc. BiotechnologyHealth Technology PharmatrophiX, Inc. develops a drug technology targeting neurodegenerative disorders. The firm is currently focusing on Alzheimer''s disease treatment. It has two development programs, p75 receptor program and Trk ligand program which targets a spectrum of neurological and non-neurological disorders. The company was founded by Frank M. Longo in 2005 and is headquartered in Raleigh, NC. | Health Technology |